Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000540836 | SCV000644368 | likely benign | Tuberous sclerosis 2 | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001016469 | SCV001177428 | uncertain significance | Hereditary cancer-predisposing syndrome | 2019-10-11 | criteria provided, single submitter | clinical testing | The c.2743-4C>T intronic variant results from a C to T substitution 4 nucleotides upstream from coding exon 24 in the TSC2 gene. This nucleotide position is not well conserved in available vertebrate species. Using the BDGP and ESEfinder splice site prediction tools, this alteration is predicted to weaken the efficiency of the native splice acceptor site; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV001538957 | SCV001756678 | likely benign | not provided | 2019-12-24 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000540836 | SCV002039683 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001016469 | SCV002533322 | likely benign | Hereditary cancer-predisposing syndrome | 2020-11-29 | criteria provided, single submitter | curation |